Sequential Gas Delivery for Neurovascular Uncoupling Assessment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for assessing multiple sclerosis-related cognition using vasoactive stimuli, such as increased inspired CO2, are imprecise due to variability in gas delivery, leading to poor sensitivity and repeatability in measuring arterial compliance and cerebrovascular reactivity.

Innovation Solution

A method involving sequential gas delivery, where a first gas with targeted oxygen and carbon dioxide concentrations is inhaled in volumes less than tidal volume minus anatomical dead space, followed by a second gas with equilibrated carbon dioxide levels, to precisely control end-tidal partial pressure of carbon dioxide and assess vascular compliance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If a fixed gas mixture with increased inspired CO2 is administered as a vasoactive stimulus, then the test can be performed with a standardized protocol, but the arterial partial pressure of CO2 (PaCO2) and timing of changes are highly variable, degrading measurement precision and test sensitivity

Engineering Contradiction:
Improvestandardized protocolVSAvoidPaCO2 control precision
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The system continuously monitors end-tidal CO2 (EtCO2) levels and uses this feedback to dynamically adjust the inspired CO2 concentration in real-time, ensuring precise control of PaCO2 despite inter-subject variability in respiratory physiology

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The gas delivery system transitions from a static fixed gas mixture approach to a dynamic adaptive system that continuously adjusts CO2 delivery based on real-time EtCO2 measurements and subject-specific respiratory parameters

Inventive Principle:
Principle #15Dynamics

2Ease of operation

If a fixed gas mixture is used to provide vasoactive stimulus, then the test protocol is simple to implement, but the magnitude of variability in the stimulus adds variability to arterial compliance measurements, degrading test sensitivity

Engineering Contradiction:
Improveprotocol simplicityVSAvoidtest sensitivity
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

Real-time EtCO2 monitoring provides continuous feedback that allows the system to compensate for subject-specific variability in respiratory mechanics and gas exchange, thereby standardizing the actual vasoactive stimulus delivered despite protocol simplicity

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system automatically adapts to each subject's unique respiratory physiology by using their own EtCO2 measurements to guide CO2 delivery adjustments, eliminating the need for complex manual calibration while improving reliability

Inventive Principle:
Principle #25Self-service

3Device complexity

If fixed gas delivery is used, then the equipment requirements are minimal, but the timing of changes to PaCO2 cannot be precisely controlled, reducing measurement precision

Engineering Contradiction:
Improveequipment simplicityVSAvoidtiming precision
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The system uses real-time EtCO2 feedback to precisely time the delivery of CO2 adjustments, synchronizing the vasoactive stimulus with measured physiological responses and enabling accurate determination of cerebrovascular reactivity timing

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The system pre-calculates the optimal timing and magnitude of CO2 delivery adjustments based on subject-specific respiratory parameters obtained before the test, allowing precise temporal control of the vasoactive stimulus

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for precise control of vascular responses, improving the sensitivity and repeatability of the test, enabling accurate designation of normal and abnormal test results by targeting specific end-tidal CO2 levels and reducing variability, thereby enhancing the assessment of multiple sclerosis-related cognition and neurovascular uncoupling.

Implementation Method 1

The first gas also contains a concentration of carbon dioxide required to target an end-tidal concentration of carbon dioxide and thereby provide a vasoactive stimulus to the subject to assess vascular compliance

Methodology Applied
Scientific EffectVasoactive stimulus:

Data Source

PatentUS11998351B2Testing for neurovascular uncoupling in multiple sclerosis using sequential gas delivery versus fixed inspired CO<sub>2</sub>
Publication Date: 2024.06.04 THORNHILL SCI INC
  • US11998351B2 patent drawing
  • US11998351B2 patent drawing
  • US11998351B2 patent drawing

AI summary

An apparatus and method for assessing vascular compliance in subjects with multiple sclerosis using sequential gas delivery is provided. The apparatus includes a gas delivery device and a processor. The processor controls the gas delivery device to deliver a first and second gas during a single inspiration. The first gas contains a mixture of oxygen and carbon dioxide necessary to target an end-tidal concentration of the two gases. The second gas includes a concentration of carbon dioxide equal to the target end-tidal concentration of carbon dioxide.